1. Cancer Salivary Biomarkers for Tumours Distant to the Oral Cavity
   Óscar Rapado-González et al, 2016, IJMS CrossRef
2. The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma
   Maria Diab et al, 2016, JCM CrossRef
3. Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers
   Tsutomu Kawaguchi et al, 2016, IJMS CrossRef
4. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation
   Kai Qu et al, 2017, Sci Rep CrossRef
5. Circulating miR-765 and miR-149: Potential Noninvasive Diagnostic Biomarkers for Geriatric Coronary Artery Disease Patients
   Md Sayed Ali Sheikh et al, 2015, BioMed Research International CrossRef
6. New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
   Erika Larrea et al, 2016, IJMS CrossRef
7. Mechanistic roles of microRNAs in hepatocarcinogenesis: A study of thioacetamide with multiple doses and time-points of rats
   Harsh Dweep et al, 2017, Sci Rep CrossRef
8. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer
   LI-XU YAN et al, 2016 CrossRef
9. Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma
   Shuhei Komatsu et al, 2015, Expert Opinion on Biological Therapy CrossRef
10. Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy
    Margaret G Keane et al, 2017, F1000Res CrossRef
11. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.
    Jisce R Puik et al, 2017, Pharmacogenomics CrossRef
12. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids
    Taisuke Imamura et al, 2016, WJG CrossRef
13. Challenges of deciphering gastric cancer heterogeneity
    Petra Hudler, 2015, WJG CrossRef
14. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
    Takahiro Kishikawa et al, 2015, World J. Gastroenterol. CrossRef
15. Non-coding landscapes of colorectal cancer.
    Marco Ragusa et al, 2015, World J Gastroenterol CrossRef
16. High-Throughput miRNA Sequencing Reveals a Field Effect in Gastric Cancer and Suggests an Epigenetic Network Mechanism
    Monica B. Assumpção et al, 2015, Bioinformatics and Biology Insights CrossRef
17. Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas
    Kiara A. Tulla et al, 2017, Langenbecks Arch Surg CrossRef
18. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.
    E Giovannetti et al, 2017, Semin Cancer Biol CrossRef
19. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma
    Kunihiko Takahasi et al, 2018, J Hepatobiliary Pancreat Sci CrossRef
20. MicroRNA-221-3p is up-regulated and serves as a potential biomarker in pancreatic cancer
    Feng Li et al, 2018, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
21. Analysis of circulating microRNAs and their post-transcriptional modifications in cancer serum by on-line solid-phase extraction capillary electrophoresis-mass spectrometry
    Roger Pero-Gascon et al, 2018, Anal. Chem. CrossRef
22. Systematic Review and Meta-Analysis of Diagnostic Accuracy of miRNAs in Patients with Pancreatic Cancer
    Xiao Sun et al, 2018, Disease Markers CrossRef
23. The Glucose-Regulated MiR-483-3p Influences Key Signaling Pathways in Cancer
    Felice Pepe et al, 2018, Cancers CrossRef
24. Blood-Derived microRNAs for Pancreatic Cancer Diagnosis: A Narrative Review and Meta-Analysis
    Xiaodong Li et al, 2018, Front. Physiol. CrossRef
25. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis
    Xin Zhou et al, 2018, Gene CrossRef
26. IGF2-derived miR-483-3p contributes to macrosomia through regulating trophoblast proliferation by targeting RB1CC1
    Jing Li et al, 2018 CrossRef
27. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
    Xiaoping Zhang et al, 2019, Oncogene CrossRef
28. Dysregulation of key microRNAs in pancreatic cancer development
    Behzad Baradaran et al, 2019, Biomedicine & Pharmacotherapy CrossRef
29. null
    Vikas Ghai et al, 2019 CrossRef
30. Novel prognostic markers within the CD44‐stromal ligand network in pancreatic cancer
    Oskar Franklin et al, 2018, J Pathol Clin Res; CrossRef
31. miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma
    Anteneh A. Tesfaye et al, 2019, The American Journal of Pathology CrossRef
32. Genetic variant in miR-21 binding sites is associated with colorectal cancer risk
    Lisheng Xie et al, 2018, J Cell Mol Med CrossRef
33. MicroRNA replacement therapy in cancer
    Homa Mollaei et al, 2019, J Cell Physiol CrossRef
34. Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients
    Sachiyo Kawamura et al, 2019, J Hepatobiliary Pancreat Sci CrossRef
35. Increased Expression of miR-483-3p Impairs the Vascular Response to Injury in Type 2 Diabetes
    Kira Kuschnerus et al, 2019, Diabetes CrossRef
36. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma
    So Nakamura et al, 2019, Ann Surg Oncol CrossRef
37. TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer
    Davide Melisi et al, 2019, Cancer Chemother Pharmacol CrossRef
38. Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
    Natalia Anahi Juiz et al, 2019, Front. Oncol. CrossRef
39. Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma
    Cong Wang et al, 2016, Br J Cancer CrossRef
40. Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities
    Claudio Pulito et al, 2017, Cell Discov CrossRef
41. null
    Petra Vychytilova-Faltejskova et al, 2015 CrossRef
42. null
    Sabita N. Saldanha et al, 2016 CrossRef
43. Identification of Upregulated HNRNPs Associated with Poor Prognosis in Pancreatic Cancer
    Lu Qiao et al, 2019, BioMed Research International CrossRef
44. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus
    Xin Dai et al, 2016, Journal of Diabetes CrossRef
45. The role of miRNAs in cutaneous squamous cell carcinoma
    Xin Yu et al, 2016, J. Cell. Mol. Med. CrossRef
46. The role of exosomes in the pathogenesis of pancreatic ductal adenocarcinoma.
    Stuart M Robinson et al, 0 CrossRef
47. null
    Maria Diab et al, 2019 CrossRef
48. Droplet digital PCR and qRT-PCR to detect circulating miR-21 in laryngeal squamous cell carcinoma and pre-malignant laryngeal lesions
    Li Wei et al, 2016, Acta Oto-Laryngologica CrossRef
49. Circulating biomarkers to monitor cancer progression and treatment
    Suthee Rapisuwon et al, 2016, Computational and Structural Biotechnology Journal CrossRef
50. Surgical and molecular pathology of pancreatic neoplasms.
    Wenzel M Hackeng et al, 2016, Diagn Pathol CrossRef
51. MicroRNA-483-3p Promotes Proliferation, Migration, and Invasion and Induces Chemoresistance of Wilms’ Tumor Cells
    Guanghua Che et al, 2019, Pediatr Dev Pathol CrossRef
52. miR‐483‐3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8 oncogene
    Mohammad‐Nazir Menbari et al, 2019, J Cell Physiol CrossRef
53. Circulating microRNAs in cancer: Hope or hype?
    Rajbir Singh et al, 2016, Cancer Letters CrossRef
54. Screening for microRNA-based diagnostic markers in hepatic alveolar echinococcosis
    Bin Ren et al, 2019, Medicine CrossRef
55. Application of nanoparticle technology in the treatment of Systemic lupus erythematous
    Davood Rostamzadeh et al, 2016, Biomedicine & Pharmacotherapy CrossRef
56. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer
    Neveen Abd El Moneim Hussein et al, 2017, J Cancer Res Clin Oncol CrossRef
57. Recent progress toward the use of circulating microRNAs as clinical biomarkers
    Vikas Ghai et al, 2016, Arch Toxicol CrossRef
58. null
    Gabriel D. Dakubo, 2017 CrossRef
59. Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma
    Pascal Syren et al, 2017, Scandinavian Journal of Gastroenterology CrossRef
60. Clinical value of circular RNAs and autophagy-related miRNAs in the diagnosis and treatment of pancreatic cancer
    Pei-Cheng Jiang et al, 2019, Hepatobiliary & Pancreatic Diseases International CrossRef
61. The Neglected Insulin: IGF-II, a Metabolic Regulator with Implications for Diabetes, Obesity, and Cancer
    null Holly et al, 2019, Cells CrossRef
62. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s)
    Joseph Carmicheal et al, 2019, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
63. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators
    Afra Z. Daoud et al, 2019, BMC Cancer CrossRef
64. Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer
    Tommaso Mazza et al, 2020, Front. Oncol. CrossRef
65. Evaluation of the clinical value of circulating miR-101, miR-187 and miR-21 in neonatal sepsis diagnosis and prognosis
    Rabab F. Salim et al, 2020, Egypt J Med Hum Genet CrossRef
66. Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging
    Ajaykumar C. Morani et al, 2020, Radiology: Imaging Cancer CrossRef
67. Analysis of microRNA expression in peripheral blood monocytes of three Traditional Chinese Medicine (TCM) syndrome types in psoriasis patients
    Yue Lu et al, 2020, Chin Med CrossRef
68. Long-Term Exercise Alters the Profiles of Circulating Micro-RNAs in the Plasma of Young Women
    Fan Li et al, 2020, Front. Physiol. CrossRef
69. CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors
    Yiqun Zhang et al, 2017, Oncotarget CrossRef
70. Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis
    Xin Guo et al, 2017, Oncotarget CrossRef
71. miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial
    Khurum Khan et al, 2016, Oncotarget CrossRef
72. Extracellular miRNA-21 as a novel biomarker in glioma: Evidence from meta-analysis, clinical validation and experimental investigations.
    Kai Qu et al, 2016, Oncotarget CrossRef
73. IGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancer
    Hengmi Cui et al, 2016, Oncotarget CrossRef
74. Micro RNA Sensing with Green Emitting Silver Nanoclusters
    Liam E. Yourston et al, 2020, Molecules CrossRef
75. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases
    Satoshi Nishiwada et al, 2020, Gastroenterology CrossRef
76. miR‑128 induces pancreas cancer cell apoptosis by targeting MDM4
    Hongchao Han et al, 2018, Exp Ther Med CrossRef
77. null
    Bo Kong et al, 2020 CrossRef
78. Prognostic value of microRNAs in pancreatic cancer: a meta-analysis
    Fei Zhao et al, 2020, Aging CrossRef
79. The involvement of exosomes in the diagnosis and treatment of pancreatic cancer
    Abakundana Nsenga Ariston Gabriel et al, 2020, Mol Cancer CrossRef
80. microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance
    Bernice Monchusi et al, 2020, Genes Cancer CrossRef
81. Reviews on Current Liquid Biopsy for Detection and Management of Pancreatic Cancers
    Karolina Elżbieta Kaczor-Urbanowicz et al, 2020, Pancreas CrossRef
82. Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma
    Geeta G. Sharma et al, 2020, Seminars in Cancer Biology CrossRef
83. The diagnostic value of exosomal miRNAs in human bile of malignant biliary obstructions
    Xianxiu Ge et al, 2020, Digestive and Liver Disease CrossRef
84. Hsa_circ_0123190 acts as a competitive endogenous RNA to regulate APLNR expression by sponging hsa-miR-483-3p in lupus nephritis
    Chunyi Zhang et al, 2021, Arthritis Res Ther CrossRef
85. Developing a nano-biosensor for early detection of pancreatic cancer
    Isra Rawashdeh1 et al, 2021, SR CrossRef
86. Molecular Approaches Using Body Fluid for the Early Detection of Pancreatic Cancer
    Kennichi Satoh, 2021, Diagnostics CrossRef
87. miR-21: a non‐specific biomarker of all maladies
    Ana E. Jenike et al, 2021, Biomark Res CrossRef
88. MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing
    Natsuhiko Kuratomi et al, 2021, IJMS CrossRef
89. Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC
    Huilin Shao et al, 2021, OTT CrossRef
90. Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy
    Maria Mortoglou et al, 2021, Translational Oncology CrossRef
91. Oral administration of EGCG solution equivalent to daily achievable dosages of regular tea drinkers effectively suppresses miR483-3p induced metastasis of hepatocellular carcinoma cells in mice
    Qingzheng Kang et al, 2021, Food Funct. CrossRef
92. Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside
    Md. Hafiz Uddin et al, 2021, Cancers CrossRef
93. Cancer therapy-related cardiac dysfunction: is endothelial dysfunction at the heart of the matter?
    Crizza Ching et al, 2021 CrossRef
94. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?
    Robert S O'Neill et al, 2021, WJG CrossRef
95. Pathology and Molecular Characteristics of Pancreatic Cancer
    Joseph F. Kearney et al, 2021, Surgical Oncology Clinics of North America CrossRef
96. MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer
    Tao Xia et al, 2021, Mol Cell Biochem CrossRef
97. Upregulation of serum exosomal miR-21 was associated with poor prognosis of acute myeloid leukemia patients
    Xingang LI et al, 2021, Food Sci. Technol CrossRef
98. The Role of microRNA in Pancreatic Cancer
    Beata Smolarz et al, 2021, Biomedicines CrossRef
99. The Role of Circulating MicroRNAs in Patients with Early-Stage Pancreatic Adenocarcinoma.
    Christos Kontos, 0 CrossRef
100. Emerging Role of miR-345 and Its Effective Delivery as a Potential Therapeutic Candidate in Pancreatic Cancer and Other Cancers
     Nagabhishek Sirpu Natesh et al, 2021, Pharmaceutics CrossRef
101. UCA1 Regulates the Growth and Metastasis of Pancreatic Cancer by Sponging miR-135a
     Xiaobo Zhang et al, 2017, oncol res CrossRef
102. Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer
     Wenjie Zhang et al, 2022, Cell Commun Signal CrossRef
103. Serum exosomal miR-451a acts as a candidate marker for pancreatic cancer
     Jia Chen et al, 2022, Int J Biol Markers CrossRef
104. Non-coding RNAs as liquid biopsy biomarkers in cancer
     Shusuke Toden et al, 2022, Br J Cancer CrossRef
105. MiR-29a Increase in Aging May Function as a Compensatory Mechanism Against Cardiac Fibrosis Through SERPINH1 Downregulation
     Evelyn Gabriela Rusu-Nastase et al, 2022, Front. Cardiovasc. Med. CrossRef
106. Study on the Mechanism of MicroRNA551b-5p in Severe Acute Pancreatitis Capillary Leakage Syndrome
     Qian Yao et al, 2022, Disease Markers CrossRef
107. The roles of microRNA in pancreatic cancer progression
     KT Ramya Devi et al, 2022, Cancer Investigation CrossRef
108. Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
     Valeria Merz et al, 2022, Front. Surg. CrossRef
109. Salivary TIMP1 and predicted mir-141, possible transcript biomarkers for estrus in the buffalo (Bubalus bubalis)
     Gangu Naidu Surla et al, 2022, Reproductive Biology CrossRef
110. Plasma Exosome-Derived microRNAs as Potential Diagnostic and Prognostic Biomarkers in Brazilian Pancreatic Cancer Patients
     Anelis Maria Marin et al, 2022, Biomolecules CrossRef
111. Extracellular vesicles microRNA analysis in type 1 autoimmune pancreatitis: Increased expression of microRNA-21
     Koh Nakamaru et al, 2020, Pancreatology CrossRef
112. miRNA Profiling of Magnetic Nanopore–Isolated Extracellular Vesicles for the Diagnosis of Pancreatic Cancer
     Jina Ko et al, 2018 CrossRef
113. Exosomal MicroRNA Analyses in Esophageal Squamous Cell Carcinoma Cell Lines
     Sora Kim et al, 2022, JCM CrossRef
114. Photodynamic Stromal Depletion Enhances Therapeutic Nanoparticle Delivery in 3D Pancreatic Ductal Adenocarcinoma Tumor Models
     Vida Karimnia et al, 2022, Photochem & Photobiology CrossRef
115. Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma
     Ahmad Ali et al, 2022, Cancers CrossRef
116. Effect of Photodynamic Therapy on the microRNA Level in Breast Cancer Tissues of Female Wistar Rats
     O. V. Kazakov et al, 2022, Bull Exp Biol Med CrossRef
117. Specific Antibodies to the Fragments of Meningococcal IgA1 Protease during the Formation of Immunity to Bacterial Infections
     O. V. Kotel’nikova et al, 2022, Bull Exp Biol Med CrossRef
118. Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas
     Yunzhen Qian et al, 2022, World J Surg Onc CrossRef
119. Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis
     Laura E. Kane et al, 2022 CrossRef
120. Circulating MicroRNAs as Noninvasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer: A Review
     Imteyaz Ahmad Khan et al, 2022, J Gastrointest Canc CrossRef
121. Epigenetic reprogramming in pancreatic premalignancy and clinical implications
     Wei Zhang et al, 2023, Front. Oncol. CrossRef
122. Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study
     Amy Makler et al, 2023, IJMS CrossRef
123. Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma–A Review of the Literature
     Jakub Wnuk et al, 2023, IJMS CrossRef
124. Pancreatic Cancer Biomarkers: Oncogenic Mutations, Tissue and Liquid Biopsies, and Radiomics—A Review
     Maria João Amaral et al, 2023, Dig Dis Sci CrossRef
125. Exosomal miRNAs in the microenvironment of pancreatic cancer
     Xinlei Zou et al, 2023, Clinica Chimica Acta CrossRef
126. Emerging Role of Pancreatic Stellate Cell-Derived Extracellular Vesicles in Pancreatic Cancer.
     Rohit Sarkar et al, 2023, Seminars in Cancer Biology CrossRef
127. null
     Rui Wang et al, 2023 CrossRef
128. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer
     Ahmed I. Abulsoud et al, 2023, Pathology - Research and Practice CrossRef
129. Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer
     Mutian Lian et al, 2023, CIMB CrossRef
130. Biomarkers in Cancer Detection, Diagnosis, and Prognosis
     Sreyashi Das et al, 2023, Sensors CrossRef
131. Postbiotic butyrate: role and its effects for being a potential drug and biomarker to pancreatic cancer
     Abinaya Elango et al, 2024, Arch Microbiol CrossRef
132. The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers
     Somayeh Jafari et al, 2024, Front. Oncol. CrossRef